title: 2,N6-disubstituted adenosine analogs with antitrypanosomal and antimalarial activities.
abstract: A library of 2,N(6)-disubstituted adenosine analogs was synthesized and the analogs were tested for their antiprotozoal activities. It was found that 2-methoxy and 2-histamino and N(6)-m-iodobenzyl substitutions generally produced analogs with low levels of antiprotozoal activity. The best antiplasmodial activity was achieved with large aromatic substitutions, such as N(6)-2,2-diphenylethyl and naphthylmethyl, which could indicate a mechanism of action through aromatic stacking with heme in the digestive vacuole of Plasmodium spp. The activities against Trypanosoma cruzi trypomastigotes and Leishmania donovani amastigotes were generally low; but several analogs, particularly those with cyclopentylamino substitutions, displayed potent activities against Trypanosoma brucei rhodesiense and T. b. brucei bloodstream forms in vitro. The most active were 2-cyclopentylamino-N(6)-cyclopentyladenosine (compound NA42) and 2-cyclopentylamino-N(6)-cyclopentyladenine (compound NA134), with the nucleobase an order of magnitude more potent than the nucleoside, at 26 +/- 4 nM. It was determined that the mode of action of these purines was trypanostatic, with the compounds becoming trypanocidal only at much higher concentrations. Those 2,N(6)-disubstituted purines tested for their effects on purine transport in T. b. brucei displayed at best a moderate affinity for the transporters. It is highly probable that the large hydrophobic substitutions, which bestow high calculated octanol-water coefficient values on the analogs, allow them to diffuse across the membrane. Consistent with this view, the analogs were as effective against a T. b. brucei strain lacking the P2 nucleoside transporter as they were against the parental strain. As the analogs were not toxic to human cell lines, the purine analogs are likely to act on a trypanosome-specific target.
authors: Van't Hoff Institute for Molecular Sciences, Universiteit van Amsterdam, The Netherlands.
authors: Boris
authors: B
authors: Rodenko
authors: Alida M
authors: AM
authors: van der Burg
authors: Martin J
authors: MJ
authors: Wanner
authors: Marcel
authors: M
authors: Kaiser
authors: Reto
authors: R
authors: Brun
authors: Matthew
authors: M
authors: Gould
authors: Harry P
authors: HP
authors: de Koning
authors: Gerrit-Jan
authors: GJ
authors: Koomen
mesh_terms: D000241:Adenosine / Q000031:analogs & derivatives* / Q000737:chemistry; D000818:Animals; D000962:Antimalarials / Q000138:chemical synthesis / Q000737:chemistry / Q000494:pharmacology*; D004305:Dose-Response Relationship, Drug; D015394:Molecular Structure; D010963:Plasmodium falciparum / Q000187:drug effects; D013329:Structure-Activity Relationship; D014344:Trypanocidal Agents / Q000138:chemical synthesis / Q000737:chemistry / Q000494:pharmacology*; D014346:Trypanosoma brucei brucei / Q000187:drug effects; D014349:Trypanosoma cruzi / Q000187:drug effects
chemical_list: D000962:Antimalarials; D014344:Trypanocidal Agents; D000241:Adenosine
references: Trans R Soc Trop Med Hyg. 1999 Jul-Aug;93(4):439-42
references: 10674099
references: Mol Pharmacol. 1999 Dec;56(6):1162-70
references: 10570043
references: Parasitol Int. 2000 Jan;48(3):265-9
references: 11227767
references: Mol Pharmacol. 2001 May;59(5):1298-306
references: 11306715
references: Int J Parasitol. 2001 May 1;31(5-6):512-22
references: 11334936
references: J Med Chem. 2001 Jun 21;44(13):2080-93
references: 11405646
references: Biochem Pharmacol. 2001 Aug 1;62(3):341-8
references: 11434907
references: Drug Resist Updat. 2001 Feb;4(1):50-65
references: 11512153
references: Trop Med Int Health. 2001 Nov;6(11):899-905
references: 11703844
references: Trop Med Int Health. 2001 Nov;6(11):906-14
references: 11703845
references: Bioorg Med Chem. 2002 Mar;10(3):769-77
references: 11814867
references: Chembiochem. 2000 Nov 17;1(4):247-9
references: 11828415
references: J Comb Chem. 2002 Jul-Aug;4(4):302-14
references: 12099848
references: J Biol Chem. 2002 Jul 19;277(29):26149-56
references: 12004061
references: Science. 2002 Jul 19;297(5580):343-4
references: 12130767
references: Trends Parasitol. 2002 Aug;18(8):366-71
references: 12377287
references: Pharmacol Ther. 2003 Sep;99(3):283-309
references: 12951162
references: Eukaryot Cell. 2003 Oct;2(5):1003-8
references: 14555482
references: Lancet. 2003 Nov 1;362(9394):1469-80
references: 14602444
references: Planta Med. 2004 Aug;70(8):706-10
references: 15368649
references: Adv Parasitol. 1994;33:1-47
references: 8122565
references: FEBS Lett. 1994 Sep 19;352(1):54-7
references: 7925942
references: Ann Trop Med Parasitol. 1997 Jul;91(5):559-66
references: 9329993
references: Biochem Pharmacol. 1998 Mar 15;55(6):727-36
references: 9586944
references: Nucleosides Nucleotides Nucleic Acids. 2004 Oct;23(8-9):1441-4
references: 15571273
references: Exp Parasitol. 2005 Feb;109(2):80-6
references: 15687014
references: Antimicrob Agents Chemother. 2005 Sep;49(9):3682-9
references: 16127040
references: FEMS Microbiol Rev. 2005 Nov;29(5):987-1020
references: 16040150
references: Bioorg Med Chem. 2006 Mar 1;14(5):1618-29
references: 16249090
references: Mol Pharmacol. 2007 Mar;71(3):921-9
references: 17185380
references: Curr Pharm Des. 2007;13(6):555-67
references: 17346174
references: Drug Resist Updat. 2007 Feb-Apr;10(1-2):30-50
references: 17409013
references: J Med Chem. 2000 Nov 2;43(22):4135-50
references: 11063610